Back

Prevalence and prognostic impact of chronic obstructive pulmonary disease in patients with chronic heart failure. Data from the GISSI-Heart Failure trial.

24 May 2016 (10:48 - 10:54)
Organised by:
Congress Presentation Part of: Moderated Poster Session 6 - Comorbidities The lungs (COPD) HFA Premium Access HEART FAILURE 2016

About the speaker

Photo
Associate Professor Marco Canepa

University of Genoa - Department of Health Sciences, Genoa (Italy)

9 More presentations in this session

Presentation thumbnail
3-month survival of the improvement of functional capacity after in-hospital short courses of leg neuromuscular electric stimulation in patients with decompensated chronic heart failure
Professor M. Poltavskaya (Moscow, RU)
Abstract Slides
Presentation thumbnail
Prognostic value of right ventricular systolic function in cardiac amyloidosis
Doctor D. Bodez (Creteil, FR)
Abstract Slides
Presentation thumbnail
Estimated glomerular filtration rate formulas and acute heart failure: does it worth to complicate?
Doctor M. Madeira (Coimbra, PT)
Abstract
Presentation thumbnail
Ergoreflex overactivity in mitochondrial disease: linking skeletal myopathy to exercise intolerance, dysautonomia, and cardiac damage
Doctor A. Aimo (Pisa, IT)
Abstract Slides
Presentation thumbnail
Efficacy and safety of didpeptidyl peptidase 4 inhibitors in patients with type 2 diabetes mellitus: a meta-analysis of 116 trials
Doctor G. Savarese (Stockholm, SE)
Abstract Slides

Access the full session

Session thumbnail
Moderated Poster Session 6 - Comorbidities

The Event

Event poster

HEART FAILURE 2016

24 May 2016 10:48 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources